{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1381699993483932161.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Masashi Mizokami"}],"foaf:familyName":[{"@value":"Mizokami"}],"foaf:givenName":[{"@value":"Masashi"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1361699993483932160","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1002/hep.21698"},{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.21698"},{"@type":"URI","@value":"https://journals.lww.com/01515467-200707000-00031"},{"@type":"PMID","@value":"17596850"},{"@type":"HANDLE","@value":"2027.42/56065"}],"notation":[{"@value":"Antiviral drug-resistant HBV"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1002/hep.21698_JMs8Y4pJdXnpzU6QAwgxXCWHscp"},{"@type":"OPENAIRE","@value":"doi_dedup___::249dd23b400043721899a12484fd119e_YlrOCmdwObSRbKNVr3FxzLoqdUd"}]}